MarketLens
Sign Up

What Just Happened with Generate Biomedicines' IPO

8 months ago
SHARE THIS ON:

What Just Happened with Generate Biomedicines' IPO

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•5 days ago

Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere

Several biotechs are proceeding with IPOs and trading well while investors await Anthropic's official IPO filing, signaling steady demand for biotech listings even as a marquee tech name stays pending...
Stock News•2 months ago

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

Generate Biomedicines (GENB) shares jumped over 20% Tuesday, ahead of Wednesday's lock-up expiration that frees insiders and early investors to sell shares from its $400 million IPO.
Stock News•3 months ago

Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It?

Nvidia CEO Jensen Huang highlighted AI's potential in life sciences, backed by a partnership with Eli Lilly and an investment in Generate Biomedicines, signaling deeper healthcare market involvement.

Breaking News

View All →

Top Headlines

View More →
Stock News•26 minutes ago

Google parent Alphabet suffers nearly $500B Wall Street wipeout amid AI spending fears

Stock News•53 minutes ago

Amazon the Latest Mag 7 to Miss Q3 Estimates

Stock News•1 hour ago

20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"

Stock News•1 hour ago

Microsoft Q1: Capex Shouldn't Scare You Due To Free Cash Flow

Stock News•1 hour ago

Microsoft Took The Balanced Approach To AI - Now It's The King